Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DepoCyte for CNS Prophylaxis in Young Adults With Standard Risk ALL
NCT00944008Phase 3Terminated
- Sponsor
- Fundación PETHEMA
- Start
- Sep 2009
- Primary completion
- Jul 2012
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Phase 3, open-label trial of liposomal cytarabine in acute lymphoblastic leukemia (ALL), sponsored by Fundación PETHEMA. Started Sep 2009; status: terminated.
02
Drugs
liposomal cytarabine
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00944008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00944008.